Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Geron (GERN) over the last 16 years, with Q3 2025 value amounting to $78.1 million.

  • Geron's Cash & Equivalents rose 2945.28% to $78.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.1 million, marking a year-over-year increase of 2945.28%. This contributed to the annual value of $79.0 million for FY2024, which is 1284.29% up from last year.
  • Per Geron's latest filing, its Cash & Equivalents stood at $78.1 million for Q3 2025, which was up 2945.28% from $77.7 million recorded in Q2 2025.
  • Geron's 5-year Cash & Equivalents high stood at $189.8 million for Q1 2024, and its period low was $29.0 million during Q3 2021.
  • For the 5-year period, Geron's Cash & Equivalents averaged around $70.2 million, with its median value being $61.1 million (2022).
  • As far as peak fluctuations go, Geron's Cash & Equivalents skyrocketed by 26002.23% in 2023, and later tumbled by 5586.82% in 2025.
  • Quarter analysis of 5 years shows Geron's Cash & Equivalents stood at $34.9 million in 2021, then skyrocketed by 63.02% to $56.8 million in 2022, then rose by 23.18% to $70.0 million in 2023, then rose by 12.84% to $79.0 million in 2024, then decreased by 1.14% to $78.1 million in 2025.
  • Its Cash & Equivalents was $78.1 million in Q3 2025, compared to $77.7 million in Q2 2025 and $83.7 million in Q1 2025.